STAT3 and neoplasm: PM-73G, phosphopeptide molecular mimic that synthesized to target the SH2 domain of STAT3, reduced MVD and VEGF levels by the suppression of p-STAT3 (Tyr705) in mice bearing MDA-MB-468 tumor (Auzenne et al., 2012).